BERGER MONTAGUE Announces That A Securities Fraud Class Action Lawsuit Was Filed Against Fulgent Genetics, Inc. (NASDAQ:FLGT); Lead Plaintiff Deadline is November 21, 2022
PHILADELPHIA, PA / ACCESSWIRE / September 21, 2022 / Berger Montague informs investors that a securities fraud class action lawsuit has been filed against Fulgent Genetics, Inc. ("Fulgent") (NASDAQ: FLGT) on behalf of those who purchased Fulgent securities between March 22, 2019 and August 4, 2022, both dates inclusive (the "Class Period").
CLICK HERE TO SUBMIT YOUR FULGENT LOSSES
LEAD PLAINTIFF DEADLINE: NOVEMBER 21, 2022
CLASS PERIOD: MARCH 22, 2019 THROUGH AUGUST 4, 2022
CONTACT AN ATTORNEY TO DISCUSS YOUR RIGHTS:
According to the complaint, on August 4, 2022, Fulgent released its second quarter 2022 financial results, disclosing, among other items, that the SEC was investigating certain of Fulgent's reports filed with the SEC from 2018 through the first quarter of 2020. The release followed Fulgent's receipt of a civil investigative demand issued by the U.S. Department of Justice "related to its investigation of allegations of medically unnecessary laboratory testing, improper billing for laboratory testing, and remuneration received or provided in violation of the Anti-Kickback Statute and the Stark Law."
Following this news, Fulgent's stock price fell $11.02 per share, or 17.29%, over the following two trading days, to close at $52.72 per share on August 8, 2022.
Whistleblowers: Anyone with non-public information regarding Fulgent is encouraged to confidentially assist Berger Montague's investigation or take advantage of the SEC Whistleblower program. Under this program, whistleblowers who provide original information may receive rewards totaling up to thirty percent (30%) of recoveries obtained by the SEC. For more information, contact us.
Berger Montague, with offices in Philadelphia, Minneapolis, Washington, D.C., and San Diego, has been a pioneer in securities class action litigation since its founding in 1970. Berger Montague has represented individual and institutional investors for over five decades and serves as lead counsel in courts throughout the United States.
James Maro, Senior Counsel
Andrew Abramowitz, Senior Counsel
SOURCE: Berger Montague